Hong Kong x Boston Biotech Disrupt Night, happening during BIO 2025, is an exclusive networking evening co-hosted by Foley Hoag, Invest Hong Kong (InvestHK), Hong Kong Science and Technology Park (HKSTP), and Hong Kong Trade Development Council (HKTDC). The event will bring together top Boston and Hong Kong growth-stage founders, VCs, healthcare and pharma buyers, official representatives, and academics to learn about the rapidly growing biotech ecosystem in Hong Kong and gain insights into strategic expansion opportunities into Asia.
The fireside chat will feature the following speakers and more:
- Partner at Six Dimension Capital (Leading VC in healthtech; $1B+ AUM), Colin Wang
- CTO at HuidaGene Therapeutics (Series C biotech company), TJ Cradick
- CEO of the Hong Kong Science and Technology Parks Corporation, Mr Albert Wong
- Dean of the Faculty of Medicine at The Chinese University of Hong Kong, Prof. Philip Chiu